Guardant Health Stock Current Asset
| GH Stock | USD 18.10 0.76 4.38% |
Guardant Health fundamentals help investors to digest information that contributes to Guardant Health's financial success or failures. It also enables traders to predict the movement of Guardant Stock. The fundamental analysis module provides a way to measure Guardant Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardant Health stock.
The current Non Current Assets Total is estimated to decrease to about 402.7 M. The current Other Current Assets is estimated to decrease to about 20.6 M. Guardant | Current Asset |
Guardant Health Company Current Asset Analysis
Guardant Health's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Guardant Health Current Asset | 219.68 M |
Most of Guardant Health's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardant Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Guardant Current Asset Historical Pattern
Today, most investors in Guardant Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Guardant Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Guardant Health current asset as a starting point in their analysis.
Guardant Health Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Guardant Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Guardant Health has a Current Asset of 219.68 M. This is 89.79% lower than that of the Health Care Providers & Services sector and 77.69% lower than that of the Health Care industry. The current asset for all United States stocks is 97.65% higher than that of the company.
Guardant Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardant Health's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics of similar companies.Guardant Health is currently under evaluation in current asset category among related companies.
Guardant Fundamentals
| Return On Equity | -4.38 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (0.85) % | ||||
| Operating Margin | (0.73) % | ||||
| Current Valuation | 2.33 B | ||||
| Shares Outstanding | 121.71 M | ||||
| Shares Owned By Insiders | 4.10 % | ||||
| Shares Owned By Institutions | 93.50 % | ||||
| Number Of Shares Shorted | 7.64 M | ||||
| Price To Earning | (12.01) X | ||||
| Price To Book | 14.01 X | ||||
| Price To Sales | 3.94 X | ||||
| Revenue | 563.95 M | ||||
| Gross Profit | 293.21 M | ||||
| EBITDA | (519.63 M) | ||||
| Net Income | (479.45 M) | ||||
| Cash And Equivalents | 853.69 M | ||||
| Cash Per Share | 8.35 X | ||||
| Total Debt | 1.35 B | ||||
| Debt To Equity | 4.32 % | ||||
| Current Ratio | 6.18 X | ||||
| Book Value Per Share | 1.30 X | ||||
| Cash Flow From Operations | (324.98 M) | ||||
| Short Ratio | 4.10 X | ||||
| Earnings Per Share | (4.28) X | ||||
| Price To Earnings To Growth | (0.66) X | ||||
| Target Price | 39.06 | ||||
| Number Of Employees | 1.77 K | ||||
| Beta | 0.9 | ||||
| Market Capitalization | 2.11 B | ||||
| Total Asset | 1.79 B | ||||
| Retained Earnings | (2.14 B) | ||||
| Working Capital | 1.14 B | ||||
| Current Asset | 219.68 M | ||||
| Current Liabilities | 24.24 M | ||||
| Net Asset | 1.79 B |
About Guardant Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Guardant Health Piotroski F Score and Guardant Health Altman Z Score analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.